[Gastrectomy with radical lymphadenectomy--standard therapy of adenocarcinoma of the stomach].
From January 1992 to December 1995, 208 patients with adenocarcinoma of the stomach were admitted for surgical treatment; total gastrectomy was performed in 152 patients. Improvement of survival rates in comparison to earlier European studies could be obtained by radical resection and routinely performed D2-lymphadenectomy without an increase in morbidity or hospital lethality. The results from Japanese researchers could not be reached.
Thybusch
A
A
Klinik für Allgemeine Chirurgie und Thoraxchirurgie, Christian-Albrechts-Universität, Kiel.
Schmid
A
A
Henne-Bruns
D
D
Kremer
B
B
D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D007902:Length of Stay; D008197:Lymph Node Excision / Q000379:methods*; D009367:Neoplasm Staging; D011183:Postoperative Complications / Q000401:mortality / Q000473:pathology / Q000601:surgery; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate
Gastrektomie mit radikaler Lymphadenektomie--Standardtherapie bei Adenokarzinom des Magens.